Adults with prediabetes and a urine pH below 6.0 may have more than 3 times the risk of progressing to diabetes compared with those with a urine pH of 6.5 or higher.
In a retrospective observational cohort study, investigators recruited 6,165 adults with prediabetes who underwent routine health examinations between January 2019 and January 2023. Participants had repeated examination data, including fasting blood glucose and glycated hemoglobin measurements. Urine pH was measured using semiquantitative dipstick testing and categorized as below 6.0, 6.0 to below 6.5, or 6.5 or higher.
The investigators assessed progression from prediabetes to diabetes, reversion to normal glycemic status, persistence of prediabetes, and associations between longitudinal urine pH patterns and diabetes progression. Multivariable analyses adjusted for age, sex, body mass index, liver and kidney function indicators, lipid measures, glycated hemoglobin, and other metabolic factors.
During a median follow-up of 1.95 years, 616 participants progressed to diabetes, 968 reverted to normal glycemic status, and 4,581 remained in the prediabetes stage.
After adjustment, participants with baseline urine pH below 6.0 had 3.15 times the likelihood of diabetes progression compared with those with urine pH of 6.5 or higher. In contrast, urine pH of 6.0 to below 6.5 was not significantly associated with progression after adjustment.
Diabetes incidence rates were 71.57 per 1,000 person-years among participants with urine pH below 6.0 vs. 49.18 among those with urine pH of 6.0 to below 6.5 and 36.08 among those with urine pH of 6.5 or higher.
Longitudinal analyses showed that participants whose urine pH remained below 6.0 had 1.97 times the adjusted hazard of diabetes progression compared with those whose urine pH remained at or above 6.0. A decrease in urine pH from at least 6.0 to below 6.0 was associated with a 33% higher adjusted hazard of progression. Increasing or fluctuating urine pH patterns were not significantly associated with progression.
Although the overall distribution of urine pH trajectories did not differ significantly among participants who progressed to diabetes, remained with prediabetes, or reverted to normal glycemic status, adjusted analyses identified sustained low urine pH as associated with progression.
Subgroup analyses showed that the association between baseline urine pH below 6.0 and diabetes progression was stronger among male participants, those with nonalcoholic fatty liver disease, and those without hypertension. However, the differences between the fatty liver disease and hypertension subgroups were not statistically significant.
Low baseline urine pH remained associated with diabetes progression across the examined subgroups. Competing-risk analyses accounting for mortality also supported the primary findings, although the associations were attenuated. Baseline urine pH below 6.0 was associated with 2.25 times the likelihood of progression, while sustained urine pH below 6.0 was associated with 1.81 times the likelihood.
The retrospective observational design prevented causal conclusions, and the single-center Chinese population limited generalizability. Urine pH was measured using semiquantitative dipstick testing, with limited repeated measurements. Detailed information on dietary acid load, hydration, urine collection timing, medication use, and direct measures of insulin sensitivity was unavailable. Changes in body weight during follow-up were also not assessed. These factors may have contributed to measurement variability and residual confounding.
“Further basic and clinical studies are required to validate these findings and explore the underlying mechanisms,” wrote lead study author Sijing Luo, of the Third Affiliated Hospital of Sun Yat-Sen University in China, and colleagues.
The study authors declared no conflicts of interest.
Source: BMJ Open
